of Laboratory Diagnostics and Population Health



March 6-7, 2023 • Pendry Chicago

Project Santa Fe Foundation’s

2023 CL2.0 Workshop


Join fellow leaders across the industry to explore the convergence of laboratory diagnostics and population health.


We invite you to participate in two days of exclusive dialogue and invention, as we address critical questions that will shape the future of our collective industry.

The potential value of the clinical lab does not end at the time we release a result — rather that’s where it begins.

convergenve set up 3mod

Connect with thought leaders from around the globe

With an exclusive curriculum developed by the Project Santa Fe Foundation distinguished board of directors, our 2023 Workshop will include:

  • Hands-on roundtables
  • Cross-industry collaborations
  • Facilitated hot-topic panels and discussions
  • Engaging, informative dialogue with your peers

Join Us at the Hotel Pendry Chicago

Steeped in history, anchored in style, and set within the iconic 1929 Art Deco Carbide & Carbon building in Chicago’s loop neighborhood, Pendry Chicago is a modern luxury hotel that pays homage to both the past and the present.

You will find Pendry Chicago’s interiors contemporary and comfortable, designed with an eye for the Carbide & Carbon building’s illustrious Art Deco heritage and combined with a modern vision of luxury hospitality.

Screenshot 2023-01-30 at 5.23.47 PM

CL2.0 Workshop: CONVERGENCE led by Project Santa Fe Foundation Board of Directors

Khosrow R. Shotorbani, MBA, MT(ASCP)

President, Executive Director
Founder, CEO, Lab 2.0 Strategic Services

James M. Crawford, MD, PhD

Chair Of The Board
Executive Director and Senior VP Laboratory Services, Northwell Health

Myra L. Wilkerson, MD

Board Treasurer
Division of Laboratory Medicine, Geisinger Health System

Mark K. Fung, MD, PhD

Professor and Vice Chair Population Health, Department of Pathology and Laboratory Medicine, The Robert Larner MD College of Medicine, University of Vermont

Curtis A. Hanson, MD

Professor and Vice Chair, Extramural Laboratory Affairs, Dept. of Laboratory Medicine and Pathology, Mayo Clinic; Chief Medical Officer, Mayo Clinic Laboratories

Karen L. Kaul, MD, PhD

Duckworth Family Chair of Molecular Pathology, Chair Pathology and Laboratory Medicine, Northshore University Healthsystem; Clinical Professor of Pathology, University of Chicago Pritzker School of Medicine

Richard J. Zarbo, MD, DMD

Senior VP and Chair, Pathology and Laboratory Medicine, Henry Ford Health System

2023 CL2.0 Workshop Agenda

Join the crucial conversation with fellow leaders across the industry as we define the future business model for the clinical laboratory.  Represented at this workshop is a tremendously respected collective body of knowledge, take your seat at the table and make an important contribution as critical questions are addressed that will shape the future of our collective industry.

March 5, 2023 – Welcome Reception

5:30pm – 7:30pm

March 6, 2023 – CL2.0 Workshop Day One

8 – 8:20am: Welcome to Convergence!  

8:20 – 8:40am: How Covid Crashed the System
A Guide to Fixing American Health Care

  • David B. Nash, MD, MBA
    Founding Dean Emeritus
    Jefferson College of Population Health

8:40 – 9am: Both/And
Medicine & Public Health Together

  • Katie Kaney, DrPH, MBA, FACHE
    Author: Both/ And: Medicine & Public Health Together
    Founder: Whole Person Index

9 – 10am: The Power of Purchasing as We Transition to Value  
We all talk about value, yet we get paid for volume.  How do we align our incentives to drive change? What does value-based payment look like? How do we change the paradigm to improve outcome and reduce ‘total cost,’ not just reduce ‘cost per’ unit?   Premier Inc leads a deep-dive discussion about the future of value-based contracting for the laboratory industry as we anticipate a value-based business model, purchasing model and payment model.

  • Peter Aftosmes, VP of Strategic Supplier Engagement
    Premier Inc
  • Mark D. Povroznik, PharmD, Chief Quality Officer, WVU Medicine, United Hospital Center

10:00am – 10:30am:  BREAK and book signing!

10:30am – 12:30am: CL2.0 Customer Panel:  The Healthcare Industry is Navigating the Strategic Inflection Point
How is the healthcare industry reimagining the future to deliver the right care, for the right population, at the right time, and at the right cost?  Leaders representing CMS, CDC, Public Health, Population Health and Major Health Systems C-Suite weigh in on their visions and plans for navigating healthcare’s transition from volume to value.

  • Facilitator: Mark D. Dixon, Rph, MHA, FACHE
  • Dr. Lee Fleisher, MD
    Chief Medical Officer
    Centers for Medicare and Medicaid Services (CMS)
  • Nancy E. Cornish MD
    Medical Officer, Senior Advisor for Quality and Safety
    Center for Surveillance, Epidemiology and Laboratory Services
    Centers for Disease Control and Prevention (CDC)
  • Julia Connell
    Director, Member Insights
    Health Management Academy
  • Katie Kaney, DrPH, MBA, FACHE
    Author: Both/ And: Medicine & Public Health Together
    Founder: Whole Person Index
  • David B. Nash, MD, MBA
    Founding Dean Emeritus
    Jefferson College of Population Health

12:30 – 1:30pm: LUNCH

1:30 – 3pm: Improving Clinical & Financial Outcomes Using the CL2.0 Model
If future is about early detection, intervention, prevention, cost avoidance and risk management, what are the opportunities for the clinical lab to proactively risk stratify a  population to help triage care at early stages? What could chronic condition surveillance look like?  Project Santa Fe Foundation faculty share thought leadership through CL2.0 Position Statements, as well as multi-institutional work on CL2.0 Lab-Initiated Care Models.

  • Mark Dixon, Rph, MHA, FACHE
  •  James M. Crawford, MD, PhD,
    Sr VP of Laboratory Services, Northwell Health
  • Mark K. Fung, MD, PhD,
    Vice-Chair Population Health, Dept of Pathology & Laboratory Medicine, University of Vermont Medical
  • Elizabeth Montgomery,
    VP Learning Strategies, National Kidney Foundation
  • Kathy Swanson,
    Faculty, Project Santa Fe Foundation

3:00 – 3:15PM: BREAK

3:15 – 4:45pm: CL2.0 Business Model Panel for Lab-initiated Value-based Care
Technology doesn’t disrupt, payment does!  What is the right payment leading to the right care for the right population at the right time?  What is the business model for lab-initiated care?  How will we monetize lab’s quantifiable value amplifying the key objectives of population health?  This session discusses the alternative business model elements, alternative payment tools, tips, and frameworks that can help laboratories looking to create and execute a strategy for the future.

  • Gaurav Sharma, MD,
    Medical Director Department of Pathology, Laboratory Medicine, Henry Ford Medical Center
  • Chris Garcia, MD
    Medical Director, Computational Pathology and AI,
    Mayo Clinic
  • Michael Crossey, MD, PhD
    Project Santa Fe Foundation Board Member
    Medical Director, TriCore
  • Lena Chaihorsky
    Vice President
    Payor Innovation, Alva10 Inc.

4:45 – 7pm: Day One Summary and Networking Reception

March 7, 2023 – CL2.0 Workshop Day Two

8 – 8:10am: Welcome back

8:10 – 10am: Comprehensive Data Platform to Catalyze Clinical Action
The CL2.0 value proposition is based on near real-time, longitudinal lab data coupled with social determinants of health to create a comprehensive data platform that catalyzes clinical action. This session explores the evolving care models, patient access channels and consumer engagement channels that create the data longitudinal platform of the future.

  • David Johnson,
    4sight Health
  • Karissa Culbreath, PhD
    Medical Director and Division Chief, Infectious Disease
  • Dwayne Breining, MD
    Executive Director
    Northwell Health Laboratories
  • Kapil Parakh, MD, MPH, PhD
    Medical Lead

10 – 10:30am: BREAK

10:30 – 12pm: Industry’s Role in Amplifying the Comprehensive Data Platform
Industry serves a unique role in harnessing, curating, and amplifying the comprehensive data platform to drive clinical strategies of early detection and early care management.  CL2.0  Industry Partners discuss the power of this role, as well as how Industry can help influence necessary policy re-alignment  to properly incentivize value-based care?

  • Facilitator: Khosrow Shotorbani
    President & Executive Director, PSFF
  • Tobin Efferen, MD, MS,
    Senior Medical Director, Medical Scientific Affairs, Beckman Coulter
  • Andy Hay,
    President & CEO, Sysmex America, Inc.
  • Hong Hong Vice President, U.S. Head of Access & Government Affairs, Roche Diagnostics
  • Veena Joy, MSc, PhD,
    Sr. Manager – US Autoimmunity, Thermo Fisher Scientific
  • Melanie Pollan, PhD, MT(ASCP),
    Sr. Director, Medical & Scientific Affairs, Siemens Healthcare Diagnostic, Inc.
  • Tricia Ravalico,
    Global Director, Scientific Leadership and Education, Core Diagnostics, Abbott
  • Maricel Roberts,
    Managing Director, Americas, Inpeco
  • Kelley Sager,
    VP & GM, Clinical Decision Support Solutions, Beckman Coulter
  • Meghan Thelen, JD,
    Sr. Director, Value-Based Healthcare, bioMérieux

12 – 1pm:  LUNCH

1 – 2:30pm: PSFF Board of Directors Panel:  Pathology Leadership Driving Change
The CL2.0 Movement is about pathology and lab leaders stepping outside of the four walls of the lab and taking a seat at the table helping to design the future care models.  Are we aligning the quantifiable attributes of the clinical lab with our organization’s strategy?  Are we measuring what matters?  The Project Santa Fe Foundation Board of Directors explores these questions that will inform the pathology and lab leader job descriptions of the future.

  • Facilitator: Bob McGonnagle,
    Founding Publisher, CAP Today
  • Khosrow Shotorbani
    President & Executive Director
    Project Santa Fe Foundation
  • James M. Crawford, MD, PhD
    Sr VP of Laboratory Services
    Northwell Health;
  • Mark K. Fung, MD, PhD
    Vice-Chair Population Health
    Dept of Pathology & Laboratory Medicine, University of Vermont Medical
  • Arand Pierce, MD, Chief Medical Officer, TriCore
  • Karen L. Kaul, MD, PhD
    Chair of Pathology & Laboratory Medicine
    Northshore University Health
  • Myra Wilkerson, MD
    Chair, Division of Laboratory Medicine,
    Geisinger Health System

2:30 – 3pm: Future of the CL2.0 Movement - A “Careholder” Discussion
Project Santa Fe Foundation is embarking upon its 7th year. Engage in an interactive discussion about the role of the movement in leading change for our collective industry.